• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化儿童肝性脑病的特征及乳果糖的疗效。

Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose.

机构信息

Department of Gastroenterology, G. B. Pant Hospital, New Delhi, India.

出版信息

Saudi J Gastroenterol. 2011 Mar-Apr;17(2):138-41. doi: 10.4103/1319-3767.77246.

DOI:10.4103/1319-3767.77246
PMID:21372353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3099061/
Abstract

BACKGROUND/AIM: Hepatic encephalopathy (HE) is associated with a poor prognosis. There is paucity of data on the treatment of HE with lactulose in children with cirrhosis.

PATIENTS AND METHODS

Retrospective analysis of consecutive cirrhotic patients (<18 years) with HE was done. HE was defined according to West-Haven criteria. Response was defined as complete if patients recovered completely from HE, partial response was defined as improvement of encephalopathy by one or more grades from admission but not complete recovery, and defined as non response if patient did not show any improvement or deteriorated further even after 10 days of lactulose therapy.

RESULTS

A total of 300 patients were admitted with cirrhosis and HE (278 adults and 22 children). Of 22 patients, 16 (73%) patients had complete response to lactulose and six (27%) patients did not [three (13.5%) patients worsened (non response) and three (13.5%) did not recover fully even after 10 days of treatment (partial response)]. Comparing baseline characteristics of patients who had complete response (n=16) versus partial (n=3) and non response (n=3), there was significant difference in mean arterial pressure (78.1±10.7 vs 62.6±5.0 mmHg, P=0.003), serum sodium (131.3±3.2 vs 126.5±5.2, P=0.01) and serum creatinine (0.78±0.3 vs 1.1±0.3 mg/dl, P=0.02). We did not find any difference in baseline characteristics of these patients regarding CTP score (9.6±1.2 vs 10.6±1.2), MELD score (17.6±2.9 vs 17.1±3.4), severity of HE (2.5±0.6 vs 2.6±0.5) and etiology of precipitating factors (P=0.78).

CONCLUSIONS

Lactulose therapy causes complete recovery from hepatic encephalopathy in 73% of pediatrics patients with cirrhosis.

摘要

背景/目的:肝性脑病(HE)与预后不良有关。关于肝硬化儿童使用乳果糖治疗 HE 的数据很少。

患者和方法

对连续的肝硬化患者(<18 岁)进行回顾性分析。根据 West-Haven 标准定义 HE。完全缓解定义为患者完全从 HE 中恢复,部分缓解定义为入院后脑病程度提高一级或一级以上但未完全恢复,无反应定义为即使在乳果糖治疗 10 天后患者无任何改善或进一步恶化。

结果

共有 300 例肝硬化伴 HE 的患者(278 例成人和 22 例儿童)入院。22 例患儿中,16 例(73%)对乳果糖有完全反应,6 例(27%)无反应[3 例(13.5%)恶化(无反应),3 例(13.5%)即使治疗 10 天后也未完全恢复(部分反应)]。比较完全缓解(n=16)、部分缓解(n=3)和无反应(n=3)患者的基线特征,平均动脉压(78.1±10.7 与 62.6±5.0mmHg,P=0.003)、血清钠(131.3±3.2 与 126.5±5.2,P=0.01)和血清肌酐(0.78±0.3 与 1.1±0.3mg/dl,P=0.02)有显著差异。我们没有发现这些患者在 CTP 评分(9.6±1.2 与 10.6±1.2)、MELD 评分(17.6±2.9 与 17.1±3.4)、HE 严重程度(2.5±0.6 与 2.6±0.5)和诱发因素的病因方面有任何差异(P=0.78)。

结论

乳果糖治疗可使 73%的肝硬化儿童肝性脑病完全恢复。

相似文献

1
Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose.肝硬化儿童肝性脑病的特征及乳果糖的疗效。
Saudi J Gastroenterol. 2011 Mar-Apr;17(2):138-41. doi: 10.4103/1319-3767.77246.
2
Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.肝硬化和肝性脑病患者对乳果糖无应答的预测因素。
Eur J Gastroenterol Hepatol. 2010 May;22(5):526-31. doi: 10.1097/MEG.0b013e3283341b7d.
3
Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.肝硬化肝性脑病的二级预防:乳果糖、益生菌和无治疗的开放性、随机对照试验。
Am J Gastroenterol. 2012 Jul;107(7):1043-50. doi: 10.1038/ajg.2012.113. Epub 2012 Jun 19.
4
Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial.乳果糖与聚乙二醇 3350--电解质溶液治疗显性肝性脑病:HELP 随机临床试验。
JAMA Intern Med. 2014 Nov;174(11):1727-33. doi: 10.1001/jamainternmed.2014.4746.
5
Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.氨水平并不指导肝硬化性肝性脑病患者的临床管理。
Am J Gastroenterol. 2020 May;115(5):723-728. doi: 10.14309/ajg.0000000000000343.
6
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.肝硬化患者显性肝性脑病的一级预防:乳果糖与无乳果糖的开放性标签随机对照试验。
J Gastroenterol Hepatol. 2012 Aug;27(8):1329-35. doi: 10.1111/j.1440-1746.2012.07186.x.
7
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.一项比较利福昔明联合乳果糖与单用乳果糖治疗显性肝性脑病的随机、双盲、对照试验。
Am J Gastroenterol. 2013 Sep;108(9):1458-63. doi: 10.1038/ajg.2013.219. Epub 2013 Jul 23.
8
Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.利福昔明与乳果糖在降低肝硬化患者显性肝性脑病复发率及住院率方面的疗效比较
Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1021-7.
9
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.血清内毒素、炎症介质与轻微型肝性脑病患者治疗前后的磁共振波谱分析
J Gastroenterol Hepatol. 2013 Jul;28(7):1187-93. doi: 10.1111/jgh.12160.
10
Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.乳果糖在肝硬化并上消化道出血患者的肝性脑病预防中具有很大的潜力:一项对照随机试验的结果。
Digestion. 2013;87(2):132-8. doi: 10.1159/000346083. Epub 2013 Mar 6.

引用本文的文献

1
Pediatric Perspectives on Liver Cirrhosis: Unravelling Clinical Patterns and Therapeutic Challenges.儿童肝硬化的视角:剖析临床模式与治疗挑战
J Clin Med. 2024 Jul 22;13(14):4275. doi: 10.3390/jcm13144275.
2
Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children With Chronic Liver Disease.慢性肝病住院儿童肝性脑病的患病率及诱发因素
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101452. doi: 10.1016/j.jceh.2024.101452. Epub 2024 May 31.
3
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.不可吸收双糖与安慰剂/无干预措施的比较以及乳果糖与乳糖醇在肝硬化患者肝性脑病预防和治疗中的比较。
Cochrane Database Syst Rev. 2016 May 6;2016(5):CD003044. doi: 10.1002/14651858.CD003044.pub4.
4
Management of overt hepatic encephalopathy.显性肝性脑病的管理
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S82-7. doi: 10.1016/j.jceh.2014.04.004. Epub 2014 May 10.
5
Cirrhosis in children and adolescents: An overview.儿童和青少年肝硬化:概述
World J Hepatol. 2015 Mar 27;7(3):392-405. doi: 10.4254/wjh.v7.i3.392.
6
Disaccharides in the treatment of hepatic encephalopathy.双糖在肝性脑病治疗中的应用。
Metab Brain Dis. 2013 Jun;28(2):313-20. doi: 10.1007/s11011-013-9392-4. Epub 2013 Mar 2.

本文引用的文献

1
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.低钠血症是肝硬化患者发生肝性脑病的一个危险因素:一项采用时间依赖性分析的前瞻性研究。
Am J Gastroenterol. 2009 Jun;104(6):1382-9. doi: 10.1038/ajg.2009.293.
2
Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis.肝硬化患者的轻度脑水肿与肝性脑病的发病机制
Hepatology. 2006 Jun;43(6):1187-90. doi: 10.1002/hep.21235.
3
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.利福昔明与乳果糖治疗肝性脑病的比较:一项前瞻性随机研究。
Yonsei Med J. 2005 Jun 30;46(3):399-407. doi: 10.3349/ymj.2005.46.3.399.
4
Serum sodium predicts mortality in patients listed for liver transplantation.血清钠可预测列入肝移植名单患者的死亡率。
Hepatology. 2005 Jan;41(1):32-9. doi: 10.1002/hep.20517.
5
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.持续性腹水和低血钠可识别出肝硬化且终末期肝病模型(MELD)评分低但早期死亡风险高的患者。
Hepatology. 2004 Oct;40(4):802-10. doi: 10.1002/hep.20405.
6
Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.用于肝性脑病的非吸收性双糖:随机试验的系统评价
BMJ. 2004 May 1;328(7447):1046. doi: 10.1136/bmj.38048.506134.EE. Epub 2004 Mar 30.
7
The relationship of cirrhosis of the liver to hypertension: a study of 504 cases of cirrhosis of the liver.肝硬化与高血压的关系:对504例肝硬化病例的研究
Am J Med Sci. 1955 Dec;230(6):627-32. doi: 10.1097/00000441-195523060-00004.
8
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.利福昔明与乳梨醇治疗急性肝性脑病的比较:一项随机、双盲、双模拟、对照临床试验的结果
J Hepatol. 2003 Jan;38(1):51-8. doi: 10.1016/s0168-8278(02)00350-1.
9
Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.肝性脑病——定义、命名、诊断及量化:1998年于维也纳召开的第11届世界胃肠病学大会工作小组最终报告
Hepatology. 2002 Mar;35(3):716-21. doi: 10.1053/jhep.2002.31250.
10
End-stage Liver Disease in Children.儿童终末期肝病
Curr Treat Options Gastroenterol. 2001 Oct;4(5):409-421. doi: 10.1007/s11938-001-0006-6.